MYC and prostate carcinoma: In this present study, we describe for the first time that GUTK impedes cell cycle re-entry of quiescent PTENnull/p53WT and PTENnull/p53mut prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.